LivaNova Recognizes Epilepsy Awareness Month This November

Go back to LivaNova Recognizes Epilepsy Awareness Month This November

Livanova (LIVN) PT Raised to $89 at Needham & Company Following 3Q Beat and Raise

November 3, 2017 8:48 AM EDT

Needham & Company raised its price target on Livanova (NASDAQ: LIVN) to $89.00 (from $83.00) while maintaining a Buy rating following the company's 3Q. Revenue was $309.7M vs. consensus of $301M and non-GAAP EPS was $0.93 vs. consensus of $0.78.

For 2017, LIVN reiterated its revenue guidance of 1-3%,... More

LivaNova plc (LIVN) Tops Q3 EPS by 18c

November 2, 2017 7:14 AM EDT

LivaNova plc (NASDAQ: LIVN) reported Q3 EPS of $0.96, $0.18 better than the analyst estimate of $0.78. Revenue for the quarter came in at $309.7 million versus the consensus estimate of $300.48 million.

"We delivered solid sales and earnings performance in the third quarter, with record growth in several of our product areas," said Damien McDonald,... More